Denise Myshko

home / authors / denise-myshko

Denise Myshko is the editor of Formulary Watch.

Articles

Psoriasis skin, eczema, rash and other skin diseases. A woman hides her face, she is ashamed of her autoimmune genetic disease. Imperfect beauty. | Image credit: stockmaster - stock.adobe.com.jpg
November 30th 2023

Bimekizumab-bkzx, the Newest Psoriasis Treatment, Is Now Available

Denise Myshko

Bimekizumab-bkzx (Bimzelx) is the first dual interleukin 17A (IL-17A) and interleukin 17F (IL-17F) inhibitor to treat moderate-to-severe plaque psoriasis. It launches with a list price of $7200 per syringe.

Drug coverage represented by pills, health icons, and a stethoscope | Image credit: janews094 - stock.adobe.com
November 27th 2023

CVS Caremark Switches Up Biosimilar Coverage in 2024

Denise Myshko

As part of updates to its standard formulary, CVS Caremark has removed Amjevita and now prefers Hyrimoz and an unbranded biosimilar.

Specialty Therapies Offering Incremental Benefit Shouldn’t Be Added to Clinical Pathways, Hertler Says
October 11th 2021

Specialty Therapies Offering Incremental Benefit Shouldn’t Be Added to Clinical Pathways, Hertler Says

Denise Myshko

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Jason Porter, MD, an expert on lung cancer
Published: July 24th 2024 | Updated: July 27th 2024
Long-Term Follow-Up from CheckMate 9LA at ASCO 2024
Jason Porter, MD, an expert on lung cancer
Published: July 24th 2024 | Updated: July 27th 2024
Insights from the TROPION-Lung05 Trial at ASCO 2024
Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School
Published: July 24th 2024 | Updated: July 27th 2024
Examining Trends, Future Directions in AI and Health Care
Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD
Alfred L. Garfall, MD, an expert on multiple myeloma
Published: July 24th 2024 | Updated: July 27th 2024
Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo